CR
Chandler Robinson (Chief Executive Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $2.5M of MNPR (28,456 sh across 3 lots, as filed), executed Sep 24. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.5M
shares × price, as filed
Last traded
Sep 24
Filed Sep 28
Median ADV $24.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
MNPRRecent filings
MNPRSALE
Monopar Therapeutics Inc.
View filing →
$2.5M28,456 sh across 3 lots
Exec Sep 24
Filed Sep 28 · 8:47 PM ET MNPRSALE Monopar Therapeutics Inc. View filing → $672K
16,800 sh × $40.00
Exec Jul 14 2025
Filed Jul 16 2025 · 5:30 PM ET